Tech Company Financing Transactions
Phase Genomics Funding Round
On 3/5/2024, Phase Genomics raised $1.5 million in funding from Bill & Melinda Gates Foundation.
Transaction Overview
Company Name
Announced On
3/5/2024
Transaction Type
Venture Equity
Amount
$1,500,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to develop a new antimicrobial discovery platform.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Unddisclosed
Seattle, WA 98101
USA
Seattle, WA 98101
USA
Phone
Undisclosed
Website
Email Address
Overview
Phase Genomics' mission is to help scientists make breakthrough discoveries by providing the most complete, accurate, detailed genomes and metagenomes available from any technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ivan Liachko
Chief Technical Officer
Shawn Sullivan
VP - Operations
Kayla Young
Browse more venture capital transactions:
Prev: 3/5/2024: Limbic venture capital transaction
Next: 3/5/2024: Yuno venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record tech company VC transactions. VC investment data records on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs